483 Abryl Labs Private Jan 2022

483 Abryl Labs Private Jan 2022

Rita Kabaso FDA$119.00 - Available Now

FDA investigators audited the Abryl Labs Private - Derabassi, India facility and issued inspectional observations (via FDA 483) on 22 Jan 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Jan 2022
  • Location: Derabassi, India
  • FEI: 3015793804
Add To Cart